Cargando…
Protection against Experimental Melioidosis with a Synthetic manno-Heptopyranose Hexasaccharide Glycoconjugate
[Image: see text] Melioidosis is an emerging infectious disease caused by Burkholderia pseudomallei and is associated with high morbidity and mortality rates in endemic areas. Antibiotic treatment is protracted and not always successful; even with appropriate therapy, up to 40% of individuals presen...
Autores principales: | Scott, Andrew E., Christ, William J., George, Alison J., Stokes, Margaret G. M., Lohman, Gregory J. S., Guo, Yuhong, Jones, Matthew, Titball, Richard W., Atkins, Timothy P., Campbell, A. Stewart, Prior, Joann L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2016
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4911622/ https://www.ncbi.nlm.nih.gov/pubmed/27124182 http://dx.doi.org/10.1021/acs.bioconjchem.5b00525 |
Ejemplares similares
-
Large-Scale Synthesis of Crystalline 1,2,3,4,6,7-Hexa-O-acetyl-l-glycero-α-d-manno-heptopyranose
por: Stanetty, Christian, et al.
Publicado: (2015) -
Development of capsular polysaccharide-based glycoconjugates for immunization against melioidosis and glanders
por: Burtnick, Mary N., et al.
Publicado: (2012) -
Protection against Experimental Melioidosis following Immunisation with a Lipopolysaccharide-Protein Conjugate
por: Scott, Andrew E., et al.
Publicado: (2014) -
Interactions of Pleiotrophin with a Structurally Defined Heparin Hexasaccharide
por: Ryan, Eathen O., et al.
Publicado: (2021) -
The global impact and cost-effectiveness of a melioidosis vaccine
por: Luangasanatip, Nantasit, et al.
Publicado: (2019)